Sandra E. Juul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sandra E. Juul has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
Adam Hartman
For the PENUT Consortium
1 shared publicationAlexander Ginder
For the PENUT Consortium
1 shared publicationAmy Silvia
For the PENUT Consortium
1 shared publicationAndrea Lampland
For the PENUT Consortium
1 shared publicationAndrea Wyatt
For the PENUT Consortium
1 shared publicationAnnamarie Russow
For the PENUT Consortium
1 shared publication
Latest Publications
- Open Access
- 7 February 2022
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (2) , e2146404
Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
More than 51 000 infants were born with a birth weight less than 1500 g in the US in 2019.1 Although the proportion of extremely preterm (EP) births has remained similar over the last quarter century,2 the age of viability has shifted substantially, attributable to ongoing advances in neonatal-perinatal medicine. The chances of survival at 24 to 25 weeks now range from 75% to 90%,3,4 compared with 62% to 68% in the late 1990s and early 2000s.5,6 However, changes in the cause and timing of death among these infants remain poorly described. Understanding modern trends relating to how and when EP infants die may provide valuable data to inform discussions with families regarding prognosis.
- 7 February 2022
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (2) , e2146404
Open AccessDeaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
More than 51 000 infants were born with a birth weight less than 1500 g in the US in 2019.1 Although the proportion of extremely preterm (EP) births has remained similar over the last quarter century,2 the age of viability has shifted substantially, attributable to ongoing advances in neonatal-perinatal medicine. The chances of survival at 24 to 25 weeks now range from 75% to 90%,3,4 compared with 62% to 68% in the late 1990s and early 2000s.5,6 However, changes in the cause and timing of death among these infants remain poorly described. Understanding modern trends relating to how and when EP infants die may provide valuable data to inform discussions with families regarding prognosis.